The Comprehensive Addiction and Recovery Act is slated for mark-up in the House of Representatives’ Judiciary Committee the last week of this month and House leadership announced floor time for opioid bills, including CARA, during the 2nd week of May.

This news makes our goal to reach 200 co-sponsors in the next month even more important. We are at 112 co-sponsors and need your help to reach our goal of 200 co-sponsors by April 30th. The more co-sponsors we have, the greater the likelihood CARA will pass the House.

At this week’s National Rx Drug Abuse & Heroin Summit in Atlanta, President Obama announced additional public and private sector actions to help address the devastating prescription opioid and heroin epidemic. The President announced that The Department of Health and Human Services (HHS) issued a new proposed rule to increase the current patient limit for qualified physicians who prescribe buprenorphine to treat opioid addiction.

Coalitions are familiar with the sobering stats around prescription drug abuse: more than six million Americans age 12 and older have used a prescription drug non-medically in the past month; drug overdose is the leading cause of accidental death in the United States.; and about 5,500 Americans misuse a prescription medication for the first time every day. And studies show prescription drugs are often the gateway to heroin use, which has reached epidemic proportions in our country.

Biopharmaceutical company Mallinckrodt has expressed its support publicly regarding establishing a Prescription Drug Monitoring Program (PDMP) in Missouri, the location of its United States headquarters.

In an advertisement in the state’s newspapers, Mallinckrodt recently printed an open letter to Missouri residents to ask them to urge their legislators to pass the Narcotics Control Act (HB 1892) as soon as possible.

Since 1962, the President of the United States has proclaimed the third week of March as National Poison Prevention Week to raise awareness about the dangers of poisonings and how to prevent them. The following daily themes will be promoted in 2016: 

Just in time for National Poison Prevention Week, CADCA and AmeriCares debuted a new course, “Medicine Safety: Drug Disposal and Storage,” on

During this free course, coalition members can learn about the dangers of prescription and over-the-counter drug abuse and how you can keep your family, patients and community safe. Topics covered include:

Wednesday, the Center for Disease Control and Prevention (CDC) released a set of guidelines for primary care clinicians to follow when treating adult patients for chronic pain in out-patient settings. The recommendations established by CDC aim to provide safer, more effective care for patients with chronic pain, and ultimately reduce prescription opioid use disorder and overdose.

Learn about the dangers of prescription and over-the-counter drug abuse and how you can keep your family, patients and community safe.

“Prescription drug abuse is an epidemic that requires more than one strategy or tactic. It’s going to take a comprehensive approach that employs multiple strategies to create population-level reductions to this problem,” notes General Arthur Dean, the Chairman and CEO of CADCA. 

Today, after a week of deliberation and consideration of amendments, the U.S. Senate passed S. 524, the Comprehensive Addiction and Recovery Act (CARA), by a vote of 94-1. This is an important victory for the prevention field!

This bipartisan legislation provides numerous provisions aimed at tackling the nation's prescription drug abuse and heroin overdose epidemic, including a $5 million enhancement grant program for current and former Drug-Free Communities grantees to address prescription drug, heroin, and meth crises locally.